In addition, especially in highly glycolytic cancer cells, mitochondria are important sites of glutamine metabolism, as many important enzymes in this metabolic pathway, such as glutamic-oxaloacetic transaminase (GOT2), glutaminase (GLS1), and glutamate dehydrogenase (GLUD), localize to mitochondria [86]. This evidence concerns the gene GLUD1 and cancer.